JAKARTA - PT Kedoya Adyaraya Tbk (RSGK), manager of the Grha Kedoya Hospital (RS) network, recorded revenue growth of 18.12% in 2024 from 2023. The revenue realisation helped drive 57.58% profit growth to IDR 39.69 billion from IDR 25.18 billion.

In the 2024 Financial Report published on Monday (17/3), Juniwati Gunawan, President Director of RSGK, said that the company recorded revenue of IDR 441.07 billion, up from IDR 373.39 billion in 2023. The Inpatient segment contributed IDR310.34 billion in revenue, up 27.24% from IDR243.88 billion and Outpatient IDR130.72 billion, up 0.93% from IDR29.51 billion.

The largest contributor in the Inpatient Segment came from Drugs and Medical Supplies at IDR151.83 billion, followed by Inpatient Rooms and Actions at IDR96.62 billion, Medical Support Services at IDR46.05 billion, and Administration and others at IDR15.82 billion.

In the Outpatient Segment, drugs and medical supplies contributed IDR 62.46 billion, medical support services IDR 45.45 billion, outpatient rooms and treatments IDR 16.23 billion, and administration and others IDR 6.57 billion.

The company posted a gross profit margin of 33.85%, up slightly from 33%. Operating profit grew 86.54% to IDR 55.02 billion from IDR 29.49 billion. Profit before income tax was IDR 56.70 billion, up 80.55% from IDR 31.40 billion. (LK/LM)